adopted activity-directed combinatorial chemical synthesisstrategy to optimize this hit compound. Compound b36 was found to be the noncompetitive and the most promising one with IC50 values of 5.96 ± 0.61 μM against PHGDH. Compound b36 inhibited the proliferation of human breast cancer and ovarian cancer cells, reduced intracellular serine synthesis, damaged DNA synthesis, and induced cell cycle arrest
RADIOACTIVE IODINE LABELED ORGANIC COMPOUND OR SALT THEREOF
申请人:Saji Hideo
公开号:US20120330024A1
公开(公告)日:2012-12-27
The present invention is a compound represented by the following formula (1) or a salt thereof. Furthermore, the present invention is an imaging agent used for imaging a tau protein, the imaging agent containing a compound represented by the formula (1) below or a salt thereof. In the formula (1), R
3
is a radioactive iodine.
series of novel indolin-2-ones inhibitors against p90ribosomalS6proteinkinase2 (RSK2) were designed and synthesized and their structure–activity relationship (SAR) was studied. The most potent inhibitor, compound 3s, exhibited potent inhibition against RSK2 with an IC50 value of 0.5 μM and presented a satisfactory selectivity against 23 kinases. The interactions of these inhibitors with RSK2 were
Radioactive iodine labeled organic compound or salt thereof
申请人:Saji Hideo
公开号:US08476449B2
公开(公告)日:2013-07-02
The present invention is a compound represented by the following formula (1) or a salt thereof. Furthermore, the present invention is an imaging agent used for imaging a tau protein, the imaging agent containing a compound represented by the formula (1) below or a salt thereof. In the formula (1), R3 is a radioactive iodine.